Literature DB >> 18621534

Expression of hypoxia inducible factor-1alpha in tumors of patients with glioblastoma multiforme and transitional meningioma.

Mehmet Yasar Kaynar1, Galip Zihni Sanus, Hakan Hnimoglu, Tibet Kacira, Rahsan Kemerdere, Pinar Atukeren, Koray Gumustas, Bulent Canbaz, Taner Tanriverdi.   

Abstract

Hypoxia-inducible factor-1 alpha (HIF-1alpha) is the major transcriptional factor involved in the adaptive response to hypoxia. The aim of this study was to assess HIF-1alpha in 22 patients with transitional meningioma (TM) and 26 patients with glioblastoma multiforme (GBM). HIF-1alpha was assessed using a commercially available enzyme-linked immunosorbent assay-based HIF-1 transcription factor assay. Levels of HIF-1alpha in TM and GBM were measured using optical density at 450nm, and median values were found to be 0.35 for TM and 0.37 OD for GBM, respectively. There was no statistically significant difference between the two types of tumor (p=0.264). These findings indicate that HIF-1alpha is elevated in both TM and GBM, suggesting that although hypoxia is one of the most important and powerful stimuli for HIF-1alpha elevation and consequently angiogenesis, other mechanisms may play roles in HIF-1alpha stimulation in benign brain tumors such as TM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621534     DOI: 10.1016/j.jocn.2007.07.080

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  17 in total

1.  Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in human meningiomas.

Authors:  Y Wu; K Lucia; M Lange; D Kuhlen; G K Stalla; U Renner
Journal:  J Neurooncol       Date:  2014-07-01       Impact factor: 4.130

Review 2.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.

Authors:  René G Feichtinger; Serge Weis; Johannes A Mayr; Franz A Zimmermann; Barbara Bogner; Wolfgang Sperl; Barbara Kofler
Journal:  Neuro Oncol       Date:  2015-06-23       Impact factor: 12.300

4.  HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.

Authors:  Markus A Queisser; Laura A Dada; Nimrod Deiss-Yehiely; Martin Angulo; Guofei Zhou; Fotini M Kouri; Lawrence M Knab; Jing Liu; Alexander H Stegh; Malcolm M DeCamp; G R Scott Budinger; Navdeep S Chandel; Aaron Ciechanover; Kazuhiro Iwai; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2014-09-15       Impact factor: 21.405

5.  Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.

Authors:  Dueng-Yuan Hueng; Gu-Jiun Lin; Shing-Hwa Huang; Li-Wen Liu; Da-Tong Ju; Yuan-Wu Chen; Huey-Kang Sytwu; Chen Chang; Shih-Ming Huang; Yi-Shian Yeh; Horng-Mo Lee; Hsin-I Ma
Journal:  J Neurooncol       Date:  2010-11-30       Impact factor: 4.130

6.  Thymidine phosphorylase and hypoxia-inducible factor 1-α expression in clinical stage II/III rectal cancer: association with response to neoadjuvant chemoradiation therapy and prognosis.

Authors:  Shuhan Lin; Hao Lai; Yuzhou Qin; Jiansi Chen; Yuan Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 7.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Clinical and prognostic significance of HIF-1α in glioma patients: a meta-analysis.

Authors:  Qi Liu; Peicheng Cao
Journal:  Int J Clin Exp Med       Date:  2015-12-15

9.  Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema.

Authors:  Joanna Reszec; Adam Hermanowicz; Robert Rutkowski; Piotr Bernaczyk; Zenon Mariak; Lech Chyczewski
Journal:  J Neurooncol       Date:  2013-07-23       Impact factor: 4.130

10.  Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide.

Authors:  Alessia Lo Dico; Cristina Martelli; Cecilia Diceglie; Giovanni Lucignani; Luisa Ottobrini
Journal:  Front Oncol       Date:  2018-07-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.